{"schema":"hottub-news/story/v1","story":"st_36ogvpfxkeyscrqou4nq","title":"Lilly, Foghorn part ways; Wave's FDA-approved plans","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/lilly-foghorn-part-ways-waves-fda-approved-plans-36ogvpfxke","count":1,"items":[{"id":"n_36ogvpfxkeyscrqou4nq","seq":1386639,"kind":"article","title":"Lilly, Foghorn part ways; Wave's FDA-approved plans","url":"https://www.biopharmadive.com/news/foghorn-eli-lilly-wave-samsung-bioepis-teva-varda-hatteras/831918","published":"2026-10-02T16:25:34Z","seen":"2026-10-02T16:25:34Z","lang":"en","source":{"id":"biopharmadive.com","name":"biopharmadive.com","domain":"biopharmadive.com"},"via":"gdelt-gkg-english","topics":["science","economy","business","security"],"authors":["Gwendolyn Wu"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q1320847","name":"foghorn","type":"org"},{"id":"Q262304","name":"Wave","type":"org"},{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_36ogvpfxkeyscrqou4nq","category":"arts-culture-entertainment","category_p":0.23999999463558197,"sentiment":"neutral","tone":0.07000000029802322,"political":0.05999999865889549}]}